At 48 weeks, 93% of participants on the 12 mg dose achieved normal liver fat levels (below 5%), with a mean relative reduction of 86% in hepatic fat content
Your provider should review your medications, blood pressure history, cardiovascular risk, and overall health
Survodutide is designed for weekly administration, facilitating easier treatment adherence
Medications that act like GLP-1 receptor agonists, such as semaglutide, are designed to mimic the functions of GLP-1 in the body
One innovative therapy we offer is the Ozempic shot, a GLP-1 receptor agonist originally developed to manage type 2 diabetes and now widely recognized for its remarkable effectiveness in promoting weight loss
Diagnosing Gastroparesis According to Medline Plus, you might undergo the following exams and tests to determine if you have gastroparesis: Esophagogastroduodenoscopy (EGD) : a procedure that enables the doctor to visualize the esophagus, stomach, and upper portion of the small intestine Gastric emptying study (using isotope labeled food) Upper GI series: a group of X-rays that show your esophagus (food pipe)